Clowse, M. E. B., Wallace, D. J., Furie, R., Petri, M., Pike, M., Leszczynski, P., … Gordon, C. (2015). Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials. In ARTHRITIS & RHEUMATOLOGY (Vol. 67). WILEY-BLACKWELL.

Clowse, Megan E. B., Daniel J. Wallace, Richard Furie, Michelle Petri, Marilyn Pike, Piotr Leszczynski, C Michael Neuwelt, et al. “Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials.” In ARTHRITIS & RHEUMATOLOGY, Vol. 67. WILEY-BLACKWELL, 2015.

Clowse MEB, Wallace DJ, Furie R, Petri M, Pike M, Leszczynski P, et al. Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials. In: ARTHRITIS & RHEUMATOLOGY. WILEY-BLACKWELL; 2015.

Clowse, Megan E. B., et al. “Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials.” ARTHRITIS & RHEUMATOLOGY, vol. 67, WILEY-BLACKWELL, 2015.

Clowse MEB, Wallace DJ, Furie R, Petri M, Pike M, Leszczynski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian K, Bongardt S, Stach C, Beaudot C, Kilgallen B, Galateanu C, Gordon C. Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials. ARTHRITIS & RHEUMATOLOGY. WILEY-BLACKWELL; 2015.